Article (Scientific journals)
LncRNA AFAP1-AS1 promotes growth and metastasis of cholangiocarcinoma cells.
Shi, Xiuhui; Zhang, Hang; Wang, Min et al.
2017In Oncotarget, 8 (35), p. 58394 - 58404
Peer Reviewed verified by ORBi
 

Files


Full Text
2017_Oncotarget.pdf
Author postprint (9.62 MB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
AFAP1-AS1; cholangiocarcinoma; long noncoding RNA; metastasis; proliferation; Oncology
Abstract :
[en] We investigated the role of actin filament associated protein 1 antisense RNA1 (AFAP1-AS1) lncRNA in promoting cholangiocarcinoma (CCA). qRT-PCR analysis of patient samples showed that AFAP1-AS1 expression was higher in CCA tumors than matched adjacent non-tumor tissue. AFAP1-AS1 levels were also higher in CCA cell lines (HuCCT1 and TFK-1) than a normal biliary epithelium cell line (HIBEpic). AFAP1-AS1 knockdown in CCA cell lines using shAFAP1-AS1 reduced cell proliferation and colony formation in CCK-8 and colony formation assays, respectively. Cell cycle analysis demonstrated that AFAP1-AS1 knockdown resulted in G0/G1 cell cycle arrest and inhibition of S-G2/M transition compared to the controls. CCA cells transfected with shAFAP1-AS1 also exhibited reduced metastasis and invasiveness in Transwell and wound healing assays. This was further confirmed in xenograft experiments with nude mice using CCA cells transfected with shAFAP1-AS1 or control shRNA. AFAP1-AS1 knockdown cells produced smaller tumors, demonstrating that AFAP1-AS1 promotes tumor growth in vivo. AFAP1-AS1 knockdown also increased expression of actin filament associated protein 1 (AFAP1) and reduced cell stress filament integrity, as determined from western blot and immunofluorescence assays, respectively. These findings indicate that AFAP1-AS1 exerts oncogenic effects in CCA. We postulate that AFAP1-AS1 is a potentially useful diagnostic and prognostic biomarker and therapeutic target for CCA.
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Shi, Xiuhui  ;  Université de Liège - ULiège > Département de pharmacie ; Department of Biliary-Pancreatic Surgery, Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Zhang, Hang ;  Department of Biliary-Pancreatic Surgery, Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Wang, Min ;  Department of Biliary-Pancreatic Surgery, Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Xu, Xiaodong;  Department of Biliary-Pancreatic Surgery, Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Zhao, Yan;  Department of Biliary-Pancreatic Surgery, Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
He, Ruizhi;  Department of Biliary-Pancreatic Surgery, Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Zhang, Min;  Department of Biliary-Pancreatic Surgery, Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Zhou, Min;  Department of Biliary-Pancreatic Surgery, Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Li, Xu;  Department of Biliary-Pancreatic Surgery, Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Peng, Feng;  Department of Biliary-Pancreatic Surgery, Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Shi, Chengjian;  Department of Biliary-Pancreatic Surgery, Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Shen, Ming;  Department of Biliary-Pancreatic Surgery, Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Wang, Xin;  Department of Biliary-Pancreatic Surgery, Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Guo, Xingjun;  Department of Biliary-Pancreatic Surgery, Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Qin, Renyi;  Department of Biliary-Pancreatic Surgery, Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
More authors (5 more) Less
 These authors have contributed equally to this work.
Language :
English
Title :
LncRNA AFAP1-AS1 promotes growth and metastasis of cholangiocarcinoma cells.
Publication date :
29 August 2017
Journal title :
Oncotarget
eISSN :
1949-2553
Publisher :
Impact Journals LLC, United States
Volume :
8
Issue :
35
Pages :
58394 - 58404
Peer reviewed :
Peer Reviewed verified by ORBi
Funding text :
This study was funded by The National Natural Science Foundation of China (Grants No. 81272659 to Renyin Qin, 81602475 to Xingjun Guo, 81502633 to Xu Li, 81402443 to Feng Peng, 81301860 to Chengjian Shi, 81172064 to Ming Shen, 81372353 to Xin Wang).
Available on ORBi :
since 16 April 2025

Statistics


Number of views
39 (3 by ULiège)
Number of downloads
25 (1 by ULiège)

Scopus citations®
 
62
Scopus citations®
without self-citations
62
OpenCitations
 
55
OpenAlex citations
 
61

Bibliography


Similar publications



Contact ORBi